Doctor-led medical care · Ubi, Singapore 6844 1528 WhatsApp
Complications

Small Intestinal Bacterial Overgrowth (SIBO) and Obesity

Small intestinal bacterial overgrowth is an excess of bacteria in the small bowel that causes bloating, wind and diarrhoea; it is roughly twice as common in severe obesity and rises sharply after gastric bypass.

Plain English

Patient-Friendly Explanation

The small intestine normally holds relatively few bacteria; most of the gut's bacteria live in the large bowel. Small intestinal bacterial overgrowth, usually shortened to SIBO, means bacteria have multiplied in the small bowel, where they ferment food before it can be absorbed. The usual symptoms are bloating, abdominal distension, excessive wind, belching, diarrhoea, cramping and sometimes nausea, and because the bacteria compete for nutrients, vitamins and fats may be absorbed poorly over time. In people with obesity, and particularly in people who have had weight-loss surgery, SIBO is more common than in the general population. The prevalence in the general population is below about five per cent, whereas studies using a glucose breath test before weight-loss surgery report around fifteen to seventeen per cent, and studies using a lactulose breath test report up to about forty per cent. A pooled analysis of five studies found roughly twice the risk in severe obesity. After a gastric bypass the picture changes markedly: pooled data from eight studies and 893 patients found SIBO in about twenty-nine per cent within three years of surgery and about fifty-three per cent more than three years afterwards. This matters for weight management because in one cohort patients with a positive breath test after bypass lost significantly less weight, about twenty-six per cent of their starting weight compared with twenty-nine per cent, and ate less, so unrecognised overgrowth can look like a poor response to surgery. Several factors explain the link: altered intestinal movement, reduced stomach acid, the anatomical changes of bypass or sleeve surgery, changes in bile flow and the frequent use of acid-suppressing medication. The diagnosis is made with a hydrogen and methane breath test, and treatment is usually a course of an appropriate antibiotic, sometimes with dietary adjustment.

Medical

Clinical Definition

Small intestinal bacterial overgrowth (SIBO) is defined by an excess of bacteria in the small intestine, historically by jejunal aspirate culture yielding 10^5 colony-forming units per mL or more, and in practice by glucose or lactulose hydrogen-methane breath testing. Symptoms are bloating, distension, flatulence, diarrhoea or constipation, abdominal pain and, in advanced cases, fat malabsorption with fat-soluble vitamin deficiency. Reported prevalence is below 5% in the general population. In a prospective study of 146 patients with morbid obesity awaiting bariatric surgery (mean BMI 46.1 kg/m2), a positive glucose breath test was found in 17.1% versus 2.5% of 40 healthy controls (p = 0.031), and SIBO was independently associated with severe hepatic steatosis on surgical liver biopsy (multivariate p = 0.005). A smaller series of 39 patients using a lactulose breath test reported 41%. In a prospective cohort of 357 patients tested before and after surgery, breath tests were positive in 15.4% before surgery, 10% after adjustable gastric banding and 40% after Roux-en-Y gastric bypass (p < 0.001 versus preoperative); patients with a positive test after bypass had lower energy intake (983 versus 1,271 kcal/day, p = 0.014), less weight loss (29.7 versus 37.7 kg, p = 0.002) and a lower percentage of total weight loss (25.6% versus 29.2%, p = 0.044), with similar vitamin levels. A systematic review and meta-analysis of eight studies including 893 patients found SIBO prevalence of 29% within three years of Roux-en-Y gastric bypass and 53% beyond three years, with symptoms including abdominal pain, diarrhoea, bloating, nausea, vomiting, constipation, dumping-type symptoms and irritable bowel syndrome, and with antibiotic therapy effective. A meta-analysis of five studies found approximately twice the risk of SIBO in severe obesity compared with individuals who do not have obesity. Mechanisms include altered migrating motor complex activity, reduced gastric acid and intrinsic factor secretion, surgical bypass of the duodenum and proximal jejunum, altered bile salt handling, small bowel stasis and proton pump inhibitor use. Breath testing has limited accuracy (pooled sensitivity about 52% to 55% and specificity about 82% to 83% against aspiration culture), so results are interpreted alongside symptoms rather than in isolation.

Key Insight

Why It Matters

SIBO is worth knowing about in a weight clinic for two reasons. First, chronic bloating and wind are often attributed to diet or to the surgery itself, and patients end up restricting food unnecessarily when the underlying problem is treatable with a short course of antibiotics. Second, in patients who have had a gastric bypass, a positive breath test has been associated with a smaller weight loss, so investigating unexplained bloating or poor progress is more useful than assuming poor adherence. Testing has real limitations, however: the breath test is only moderately sensitive and specific, so the decision to treat should rest on the pattern of symptoms and the test together.

Sources

Reviewed against standard medical references.

Medically reviewed by

Dr Joseph Wang

Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).

Last reviewed: October 2026

This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.

WhatsApp